Table 2 Prevalence of eligible patients according to the enrollment criteria of CANVAS, DECLARE-TIMI 58, EMPA-REG OUTCOME, and VERTIS-CV
SGLT2i CVOT | Number of patients (number of studies) | Prevalence (95% CI) | I2 (%) |
|---|---|---|---|
CANVAS | 1,510,378 (5) | 36.4 (33.3 to 39.4) | 100 |
DECLARE-TIMI 58 | 1,619,008 (5) | 49.5 (39.7 to 59.3) | 100 |
EMPA-REG OUTCOME | 1,703,519 (5) | 17.0 (10.6 to 23.4) | 100 |
VERTIS-CV | 1,330,334 (4) | 19.0 (14.4 to 23.7) | 100 |